Buy PT-141 | PT-141 10mg

PT-141 10 mg Buy PT-141, PT-141 10mg. PT-141, a cyclic heptapeptide made from Melanotan II, is also referred to as Bremelanotide and sold under the Vyleesi brand. It was designed to minimize undesirable skin-darkening activity while maintaining sexual stimulation effects. The substance targets MC3R and MC4R receptors in the central nervous system by acting as a melanocortin receptor agonist.

• Molecular weight: ~1025 g/mol
• Form: Lyophilized powder (commonly in 10 mg vials for research)
• Administration: Subcutaneous injection
• FDA Approval: June 2019 for HSDD in premenopausal women

Buy PT-141 | Characteristics

• Mechanism of Action: PT-141 increases dopaminergic signaling associated with arousal and sexual drive by stimulating melanocortin receptors in the limbic system and hypothalamus.
• Onset: Effects begin within 45–90 minutes after injection.
• Duration: Lasts 6–12 hours.
• Half-life: Approximately 2.5 hours.
• Unique Pathway: PT-141 regulates neural pathways of desire rather than acting on vascular smooth muscle, in contrast to PDE5 inhibitors (such as Viagra and Cialis).

Buy PT-141 | Effects

• Clinical trials (RECONNECT studies) in women demonstrated notable increases in sexual desire and decreases in suffering associated with low libido. When compared to a placebo, women reported more fulfilling sexual experiences.
• In Men: PT-141 has demonstrated potential in treating erectile dysfunction, particularly in situations when PDE5 medications are unsuccessful, despite not having FDA approval for men.
• Neurological Impact: By directly affecting the brain’s arousal pathways, it increases sexual motivation.
• Secondary Effects: Although this is not its main mechanism, it may indirectly increase vaginal blood flow through nitric oxide pathways. PT-141 10 mg

Benefits

• The only centrally acting medication authorized for female sexual dysfunction is the FDA-approved treatment for HSDD.
• Effective for people whose sexual dysfunction is not solely vascular, it addresses psychological and neurological factors.
• On-demand use: Provides flexibility by being administered before planned sexual activity.
• Potential use for males: Offers a substitute for guys who don’t respond to conventional ED drugs.
• Wider therapeutic potential: Studies point to potential advantages in disorders requiring motivation and dopaminergic signaling.

Considerations & Risks

• Side effects include periodic flushing, temporary elevations in blood pressure (~15%), and nausea (~40% of users).
• Skin Pigmentation: Melanocortin receptor activation brought on by repeated use may result in moderate hyperpigmentation.
• Not a daily treatment: Designed to be used sporadically as opposed to continuously